08/07/2024 Healthcare
Vidasat-M tablets combine Vildagliptin and Metformin Hydrochloride to manage type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This combination effectively controls blood sugar levels. Dosage should be directed by a healthcare provider to ensure optimal diabetes management and minimize side effects.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
Vidasat-M tablets combine Vildagliptin and Metformin Hydrochloride to manage type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that increases insulin...
Ecotin SR tablets combine Teneligliptin (20 mg) and Metformin Hydrochloride (500 mg) for managing type 2 diabetes. Teneligliptin is a DPP-4 inhibitor ...
Siaglide-M 50/500 Tablet SR is prescribed to help manage blood sugar levels in individuals with type II diabetes mellitus, alongside a proper diet and...
Abvida-M 50/1000 Eazy Glide Tablet SR is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus.
More Details